Hot Features
Premium
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 91,477 |
|
|||||
| News | - | ||||||
| Day High | 19.99 | Low High |
|||||
| Day Low | 19.05 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Myriad Genetics Inc | MYGN | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -0.17 | -0.87% | 19.30 | 10:35:12 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 19.67 | 19.05 | 19.99 | 19.47 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 1,266 | 91,477 | US$ 19.25 | US$ 1,761,209 | - | 13.82 - 24.21 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 10:36:24 | 99 | US$ 19.31 | USD |
Myriad Genetics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 1.72B | 89.87M | - | 753.2M | -263.3M | -2.93 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Myriad Genetics News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical MYGN Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 18.15 | 20.05 | 17.90 | 19.23 | 841,953 | 1.15 | 6.34% |
| 1 Month | 20.50 | 21.06 | 17.90 | 19.35 | 604,708 | -1.20 | -5.85% |
| 3 Months | 22.05 | 23.75 | 17.90 | 21.16 | 656,654 | -2.75 | -12.47% |
| 6 Months | 15.98 | 23.75 | 15.785 | 20.08 | 676,734 | 3.32 | 20.78% |
| 1 Year | 21.57 | 24.21 | 13.82 | 19.64 | 607,525 | -2.27 | -10.52% |
| 3 Years | 30.86 | 36.9547 | 13.82 | 22.59 | 579,983 | -11.56 | -37.46% |
| 5 Years | 32.05 | 48.40 | 9.24 | 22.40 | 731,466 | -12.75 | -39.78% |
Myriad Genetics Description
| Myriad Genetics is a molecular diagnostics company that provides testing services designed to assess an individual's risk of developing a disease. The firm produces MyRisk, a 35-gene panel with the capability to identify the elevated risk of developing eight types of cancer. Other diagnostic products include BRACAnalysisCDx, the FDA-approved companion diagnostic for PARP inhibitors; GeneSight, which helps improve responses to psychotropic drugs for patients suffering from depression; Prequel, with is a noninvasive prenatal test; and Prolaris, which identifies prostate cancer patients that can pursue active surveillance. The firm offers biomarker discovery and companion diagnostic services to pharma and biotech companies. |
